• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC. VITEK® 2 AST-YS08 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC. VITEK® 2 AST-YS08 TEST KIT Back to Search Results
Catalog Number 420739
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
A customer from (b)(6) notified biomérieux of false susceptible voriconazole results when testing a candida glabrata biologie prospective survey strain (myco 2018-2a) with the vitek® 2 ast-ys08 test kit, lot 2880585403.The customer obtained the following results: voriconazole susceptible (mic = 1) two times and intermediate (mic = 2) one time.The customer retested the strain using a different lot of the vitek 2 ys08 cards and obtained a resistant result (mic = 4).The expected result for this strain is resistant.As there is no patient associated with this quality control strain, there is no adverse event related to any patient's state of health.A biomérieux internal investigation has been initiated.
 
Manufacturer Narrative
This investigation was initiated due to a customer reporting a false susceptible voriconazole (vrc) result with candida glabrata bp survey strain (myco 2018-2a) on vitek® 2 v7.01 ast-ys08 card.Identification of the submitted organism was confirmed and testing included one card from the customer lot (2880585403 cl) of ast-ys08 cards, as well as one card from a random lot (2880600203 rl).The reference method broth microdilution (bmd), used for the development of the incriminated drug (vrc01n formulary), was performed in parallel of vitek 2 testing: vrc mic = 4 mg/l resistant.On vitek 2 v7.01 ast-ys08 card (aes parameters : casfm eucast 2016 + phenotypic) : the vrc values (4 and >/= 8 mg/l) are within essential agreement (within 1 doubling dilution for the value at >/= 8) compared to the reference mic (bmd - 4 mg/l resistant), without category error.Susceptible customer results are not reproduced in-house on both lots tested.The vitek 2 ast-ys08 cards performed as intended and no further action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-YS08 TEST KIT
Type of Device
VITEK® 2 AST-YS08 TEST KIT
Manufacturer (Section D)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
Manufacturer Contact
candace martin
595 anglum road
saint louis, MO 63042
MDR Report Key7654630
MDR Text Key113394829
Report Number1950204-2018-00241
Device Sequence Number1
Product Code LON
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K092454
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 09/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/04/2019
Device Catalogue Number420739
Device Lot Number2880585403
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/07/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/02/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-